Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

Gwan Gyu Song; Young Ho Lee

doi:10.1007/s40261-019-00817-1

Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

Gwan Gyu Song, Young Ho Lee

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

Original language	English
Number of pages	1
Journal	Clinical Drug Investigation
Volume	39
Issue number	7
DOIs	https://doi.org/10.1007/s40261-019-00817-1
Publication status	Published - 2019 Jul 1

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1007/s40261-019-00817-1

Fingerprint

Dive into the research topics of 'Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)'. Together they form a unique fingerprint.

Cite this

Song, G. G., & Lee, Y. H. (2019). Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w). Clinical Drug Investigation, 39(7). https://doi.org/10.1007/s40261-019-00817-1

Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w). / Song, Gwan Gyu; Lee, Young Ho.
In: Clinical Drug Investigation, Vol. 39, No. 7, 01.07.2019.

Research output: Contribution to journal › Comment/debate › peer-review

Song, GG & Lee, YH 2019, 'Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)', Clinical Drug Investigation, vol. 39, no. 7. https://doi.org/10.1007/s40261-019-00817-1

Song GG, Lee YH. Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w). Clinical Drug Investigation. 2019 Jul 1;39(7). doi: 10.1007/s40261-019-00817-1

@article{00656fb66bec4519a179c47d18d8bdaf,

title = "Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)",

abstract = "The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.",

author = "Song, {Gwan Gyu} and Lee, {Young Ho}",

year = "2019",

month = jul,

day = "1",

doi = "10.1007/s40261-019-00817-1",

language = "English",

volume = "39",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis International Ltd",

number = "7",

}

TY - JOUR

T1 - Correction to

T2 - Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

AU - Song, Gwan Gyu

AU - Lee, Young Ho

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

AB - The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

UR - http://www.scopus.com/inward/record.url?scp=85067650117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067650117&partnerID=8YFLogxK

U2 - 10.1007/s40261-019-00817-1

DO - 10.1007/s40261-019-00817-1

M3 - Comment/debate

C2 - 31197660

AN - SCOPUS:85067650117

SN - 1173-2563

VL - 39

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 7

ER -

Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this